Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Monday, February 14, 2011 | Web News
On February 11, 2011 we initiated a short-term trading position in shares of NBIX @ $8.06 The company reported 2010 fourth quarter EPS...
See All Research...
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders.

Web site: http://www.neurocrine.com

Last updated February 11, 2011


Market Data powered by QuoteMedia. Terms of Use